Evidence map›Paper›PMID 34885848›Full record

ReviewMolecules (Basel, Switzerland)2021

Human Group IIA Phospholipase A

Kieran F Scott, Timothy J Mann, Shadma Fatima, Mila Sajinovic, Anshuli Razdan, Ryung Rae Kim, Adam Cooper, Aflah Roohullah, Katherine J Bryant, Kasuni K Gamage and 7 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Human Group IIA Secreted Phospholipase AInternational journal of molecular sciences · 2026
    Review
  2. The innate immune mediator group IIA secreted phospholipase AFrontiers in cell and developmental biology · 2026
    Article
  3. Targeting secreted PLACell death & disease · 2025
    Article
  4. Secretory phospholipase ACommunications biology · 2025
    Article
  5. Article
  6. Review
  7. Identification of a Dual Inhibitor of Secreted Phospholipase APharmaceuticals (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Kieran F ScottSchool of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.ORCID 0000-0002-6012-4107
Timothy J MannSchool of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.
Shadma FatimaSchool of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.
Mila SajinovicIngham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.
Anshuli RazdanIngham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.
Ryung Rae KimSchool of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0003-3810-9514
Adam CooperSchool of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.
Aflah RoohullahSchool of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.
Katherine J BryantSchool of Photovoltaic and Renewable Energy Engineering, UNSW Sydney, Sydney, NSW 2052, Australia.
Kasuni K GamageSchool of Science, Western Sydney University, Campbelltown, NSW 2560, Australia.
David G HarmanSchool of Science, Western Sydney University, Campbelltown, NSW 2560, Australia.
Fatemeh VafaeeSchool of Biotechnology and Biological Sciences, University of New South Wales (UNSW Sydney), Sydney, NSW 2052, Australia.
Garry G GrahamDepartment of Clinical Pharmacology, St Vincent's Hospital Sydney, Darlinghurst, NSW 2010, Australia.
W Bret ChurchSchool of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0002-8033-5518
Pamela J RussellAustralian Prostate Cancer Research Centre-QUT, Brisbane, QLD 4102, Australia.
Qihan DongChinese Medicine Anti-Cancer Evaluation Program, Greg Brown Laboratory, Central Clinical School and Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.
Paul de SouzaSchool of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.
Camden and Campbelltown Hospitals · AUThe University of Sydney · AUUNSW Sydney · AUIngham Institute · AUProstate Cancer Foundation of Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phospholipase A

Indexed as

Drug DevelopmentGroup II Phospholipases A2HumansNeoplasmsPrognosisGroup II Phospholipases A2cancerchronic inflammationdrug developmenteicosanoidprostaglandin

Identifiers

PMID34885848
PMCPMC8658914
OpenAlexW3217032183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.